GlassScriptPhysician profile
Thomas G Zwick
NPI 1043217235
$108,189.68
in general payments reported to CMS, 2019-2025
46 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,550 · 2021: $4,831 · 2022: $12K · 2023: $1,546 · 2024: $23K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Consulting Fee: $24K · Travel and Lodging: $5,691 · Food and Beverage: $5,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,960.00 |
| Consulting Fee | $24,480.00 |
| Travel and Lodging | $5,691.11 |
| Food and Beverage | $5,549.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $97,863.85 | 2019-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Medline Industries LP | $3,166.65 | 2022-2024 | |
| Treace Medical Concepts, INC. | $1,116.52 | 2022-2025 | |
| Smith+Nephew, INC. | $984.67 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Musculoskeletal Transplant Foundation INC. | $783.38 | 2019-2020 | |
| Abbvie INC. | $780.42 | 2021-2023 | Dalvance |
| Arthrex, INC. | $477.80 | 2023 | |
| Grt US Holding, INC. | $418.52 | 2022 | |
| Averitas Pharma INC. | $388.59 | 2023-2025 | Qutenza |
| Sanara Medtech INC. | $365.15 | 2020-2022 | |
| Biotissue Holdings INC. | $237.52 | 2025 | |
| Kci USA, INC. | $198.07 | 2020-2022 | |
| Convatec INC. | $153.66 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $142.00 | 2022-2025 | Nuzyra |
| Cardiovascular Systems INC. | $90.56 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hnm Stainless, LLC | $87.50 | 2024 | |
| Zyla Life Sciences, INC. | $85.41 | 2019 | |
| Stryker Corporation | $83.20 | 2019-2025 | Prostep |
| Aroa Biosurgery Incorporated | $73.63 | 2024-2025 | |
| Horizon Therapeutics Plc | $51.30 | 2019-2021 | |
| Abbott Laboratories | $46.24 | 2023-2024 | Proclaim |
| Medela LLC | $45.51 | 2019 | |
| Ets Wound Care LLC | $43.04 | 2023-2025 | Mirragen Advanced Wound Matrix |
| Acumed LLC | $38.05 | 2022 | |
| Allergan, INC. | $30.04 | 2019 | |
| Next Science LLC | $27.36 | 2024 | Xperience, Surgx, Blastx |
| Acera Surgical, INC. | $26.14 | 2022 | |
| Reprise Biomedical, INC. | $25.44 | 2024 | Miro3d |
| Polynovo North America LLC | $25.16 | 2022 | |
| Medtronic, INC. | $23.52 | 2025 | Intellis Adaptivestim |
| Innovation Technologies INC | $23.04 | 2022 | |
| Urgo Medical North America, LLC | $22.61 | 2025 | Urgoclean Ag |
| Access Pro Medical, LLC | $22.56 | 2025 | Matriderm |
| Alfasigma USA, INC. | $22.36 | 2022 | |
| Melinta Therapeutics, LLC | $22.32 | 2022 | |
| Zimmer Biomet Holdings, INC. | $21.60 | 2021 | |
| Solventum Corporation | $20.38 | 2025 | 3m Cavilon, Promogran Prisma, Activ.A.C. |
| Wound Management Technologies, INC | $19.37 | 2019 | |
| Kerecis Limited | $18.93 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Janssen Pharmaceuticals, INC | $18.81 | 2019 | |
| Merck Sharp & Dohme LLC | $18.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.91 | 2019 | |
| Pfizer INC. | $16.64 | 2020 | |
| Bioventus LLC | $15.30 | 2022 | |
| Integra Lifesciences Corporation | $15.29 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Zwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.